We looked at 54 medicinal cannabis websites to see if they followed the rules. Here’s what we found 
Patients Claim COVID Vaccines Were Administered Without Consent While Sedated, Sparking Outrage and Legal Action 
Nintendo Unveils Switch 2 Console, Launch Expected This Year 
Say it with a picture: overcoming legalese in public procurement contracts 
China's Bold Moves to Stabilize the Yuan Amid Economic Uncertainty 
U.S. Tightens Chip Export Controls, Adds Chinese AI Firms to Blacklist 
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update 
Johnson & Johnson Eyes $10 Billion Biopharma Deal with Intra-Cellular Therapies 
Weekly Market Outlook: Inflation, Earnings, and Global Economic Data in Focus 
‘AI agents’ promise to arrange your finances, do your taxes, book your holidays – and put us all at risk 
Blue Origin Prepares to Test New Glenn Rocket, Set to Rival SpaceX's Falcon Rockets 
How Justin Trudeau’s resignation could affect the future of the Canadian Dental Care Plan 
Walking into stress in 2025? Take steps now to prepare 
UBS Predicts Potential Fed Rate Cut Amid Strong US Economic Data 
A South Korean research team has developed a strip-type urine test that successfully diagnoses prostate and pancreatic cancer on-site by amplifying the optical signal of the metabolome in urine.
The joint research team is from the Korea Institute of Materials Science, Pohang University of Science and Technology, and Kyung Hee University
The surface-enhanced Raman scattering sensor that they developed can amplify the optical signal of the metabolome in urine by more than 1 billion times by forming a coral reef-shaped plasmonic nanomaterial on top of porous paper material.
A light irradiation after a 10-microliter urine droplet amplified signal of cancer metabolome on the sensor’s surface without the need to go through a separate analysis process,.
The application of an artificial intelligence-based analytical method for the spectrum signal generated through the irradiation of light into the urine can identify people with prostate cancer and pancreatic cancer with an accuracy of up to 99 percent.
